Nalaganje...
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
BACKGROUND: Mutations in the KRAS gene are one of the most frequent genetic abnormalities in ovarian carcinoma. They are of renewed interest as new epidermal growth factor receptor (EGFR)-targeted therapies are being investigated for use in ovarian carcinoma. As KRAS mutations are associated with po...
Shranjeno v:
Main Authors: | , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2009
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2671522/ https://ncbi.nlm.nih.gov/pubmed/19358724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-111 |
Oznake: |
Označite
Brez oznak, prvi označite!
|